Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
130Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $385.79M | $-18.67M | $-1.70 |
| 2024 | $602.46M | $2.09M | $0.19 |
| 2023 | $1.07B | $99.42M | $9.10 |
| 2022 | $1.60B | $143.57M | $12.82 |
| 2021 | $1.53B | $164.03M | $14.01 |
Social Signal Score
Earnings
Mon, Nov 2(in 3 months)
Consensus estimate $-0.35 per share
Typical surprise +56.9% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Aug 3$-0.28 vs $-0.65beat
- Mon, May 4$-0.19 vs $-0.55beat
- Tue, Feb 17$-0.55 vs $-0.76beat
- Mon, Nov 3$-0.21 vs $-0.01miss
- Mon, Aug 4$0.04 vs $-0.30beat
- Mon, Apr 28$-0.11 vs $-0.07miss
Estimates and results for MED via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
MEDhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newszacks.com·3d ago·Positive
Can Medifast's Coach Productivity Gains Help Revive Revenue Growth? MED's improving coach productivity and client retention point to stabilization, but a shrinking coach base remains a challenge.
View source ↗